↓ Skip to main content

Efficacy and safety of CD19-specific CAR-T cell-based therapy in secondary central nervous system lymphoma

Overview of attention for article published in Frontiers in immunology, August 2022
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (59th percentile)
  • Good Attention Score compared to outputs of the same age and source (68th percentile)

Mentioned by

twitter
5 X users

Citations

dimensions_citation
3 Dimensions

Readers on

mendeley
15 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Efficacy and safety of CD19-specific CAR-T cell-based therapy in secondary central nervous system lymphoma
Published in
Frontiers in immunology, August 2022
DOI 10.3389/fimmu.2022.965224
Pubmed ID
Authors

Huanxin Zhang, Zhiling Yan, Ying Wang, Yuekun Qi, Yongxian Hu, Ping Li, Jiang Cao, Meng Zhang, Xia Xiao, Ming Shi, Jieyun Xia, Sha Ma, Jianlin Qiao, Hujun Li, Bin Pan, Kunming Qi, Hai Cheng, Haiying Sun, Feng Zhu, Wei Sang, Depeng Li, Zhenyu Li, Junnian Zheng, Mingfeng Zhao, Aibin Liang, He Huang, Kailin Xu

X Demographics

X Demographics

The data shown below were collected from the profiles of 5 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 15 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 15 100%

Demographic breakdown

Readers by professional status Count As %
Other 3 20%
Student > Master 2 13%
Unspecified 1 7%
Student > Bachelor 1 7%
Lecturer > Senior Lecturer 1 7%
Other 2 13%
Unknown 5 33%
Readers by discipline Count As %
Medicine and Dentistry 3 20%
Unspecified 1 7%
Sports and Recreations 1 7%
Pharmacology, Toxicology and Pharmaceutical Science 1 7%
Neuroscience 1 7%
Other 1 7%
Unknown 7 47%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 27 September 2023.
All research outputs
#14,506,224
of 25,563,770 outputs
Outputs from Frontiers in immunology
#11,796
of 31,964 outputs
Outputs of similar age
#170,763
of 433,037 outputs
Outputs of similar age from Frontiers in immunology
#631
of 2,064 outputs
Altmetric has tracked 25,563,770 research outputs across all sources so far. This one is in the 42nd percentile – i.e., 42% of other outputs scored the same or lower than it.
So far Altmetric has tracked 31,964 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.4. This one has gotten more attention than average, scoring higher than 61% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 433,037 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 59% of its contemporaries.
We're also able to compare this research output to 2,064 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 68% of its contemporaries.